Skip to content

Clinical trials

Cholangiocarcinoma trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Poland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20151
20161
20171
20193
20211
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Active, not recruiting3
Completed2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
AstraZeneca1
Celon Pharma SA1
EMD Serono Research & Development Institute, Inc.1
Helsinn Healthcare SA1
Hoffmann-La Roche1
MacroGenics1
Medical University of Warsaw1
Merck Sharp & Dohme LLC1
PCI Biotech AS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma12
Gallbladder Neoplasms4
Bile Duct Neoplasms3
Biliary Tract Neoplasms3
Ovarian Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Triple Negative Breast Neoplasms3
Uterine Cervical Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.